Association Between Cancer and Sarcoidosis
- Conditions
- CancerSarcoidosis
- Registration Number
- NCT03844698
- Lead Sponsor
- University of Miami
- Brief Summary
The purpose of this study is to develop a clinical dataset of sarcoidosis patients with a diagnosis of cancer who are categorized by date of birth, sex, race/ethnicity, clinical information, laboratory and imaging information, time of sarcoidosis onset, cancer type and treatment, time of cancer diagnosis, stage and grade.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 171
- Clinical diagnosis of Sarcoidosis following cancer
- Granulomatous reaction must be proven by pathology
. Aged younger than 18 years old.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pathology Proven Sarcoidosis In Patients with Cancer up to 10 years Number of Participants With Sarcoidosis Events as Assessed by Positive Granulomatous Reaction in the Biopsies of Lung, Mediastinal Lymph Nodes, or Other Organs After Cancer Diagnosis.
- Secondary Outcome Measures
Name Time Method Cancer Cytogenetics and Sarcoidosis up to 10 years Number of Participants With Sarcoidosis Events as Assessed by Cancer Cytogenetic Profiles of Cancer.
Treatment Requirement of Sarcoidosis up to 10 years Number of Participants With Sarcoidosis Events as Assessed by Requirement of Treatment with Steroid or Other Anti-Sarcoid Medications in Patients with Cancer.
Trial Locations
- Locations (1)
University of Miami, Miller School of Medicine
🇺🇸Miami, Florida, United States